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TheGram-positive, spore-formingbacteriumPaenibacillus larvae (P. larvae) is thecausativeagentof theepizootic
American Foulbrood (AFB), a fatal brooddisease of thewestern honey bee (Apismellifera). AFB is oneof themost
destructive honeybeediseases since it is not only lethal for infected larvaebut also for thediseased colonies. Due
to the high impact of honey bees on ecology and economy this epizootic is a severe and pressing problem.
Knowledge about virulence mechanisms and the underlying molecular mechanisms remain largely elusive.
Recent genome sequencing of P. larvae revealed its potential to produce unknown secondary metabolites, like
nonribosomal peptides and peptide–polyketide hybrids. This article highlights recent ﬁndings on secondary
metabolites synthesizedbyP. larvaeanddiscusses their role invirulenceandpathogenicity towards thebee larvae.Introduction
Western honey bees (Apis mellifera) are the most widely used
managed pollinators for insect pollination-dependent agricul-
tural crop and fruit cultures worldwide. Therefore, honeybees are
seen as among the most important productive livestock.1 Agri-
cultural pollination relies strongly (about 90%) on managed
honey bees and the demand for honey bee pollination is still
increasing.2,3 A signicant reduction of the honey bee population
will lead to serious consequences for most ecosystems under
severe concomitant economic losses, not only in apiculture, but
also in the entire agriculture worldwide. Honey bees are threat-
ened by numerous pathogens, including viruses (e.g. deformed
wing virus, DWV, transmitted by the mite Varroa destructor),
fungi (e.g. Ascosphaera apis or Nosema spp.) and bacteria like
Melissococcus plutonius (causing European Foulbrood) and Pae-
nibacillus larvae (causing American Foulbrood).4 These patho-
gens pose various threats of diﬀerent severity and some of them
are even able to destroy entire colonies.Paenibacillus larvae and the American
foulbrood
A deadly bee pathogen is the Gram-positive, facultative anaer-
obic, spore-forming bacterium Paenibacillus larvae (P. larvae),Berlin, 10623, Berlin, Germany. E-mail:
olecular Microbiology and Bee Diseases,
elke.genersch@hu-berlin.de
hemistry 2015the etiological agent of the American Foulbrood (AFB).5 AFB is
occurring worldwide and leads to massive losses of entire bee
colonies every year. AFB is highly contagious and spreads very
rapidly. In many countries, AFB is a notiable disease and
infected bee hives have to be burned to contain the disease. An
eﬀective treatment of AFB does still not exist, since the under-
lying molecular characteristics of the P. larvae infection remain
largely elusive. Therefore, it is diﬃcult to develop eﬃcient
approaches to ght this severe epizootic.
Based on repetitive element PCR (repPCR) using enterobac-
terial repetitive intergenic consensus sequence (ERIC) primers,6
the species P. larvae has been classied into four diﬀerent
genotypes (ERIC I–IV) which could recently be conrmed by
multi locus sequence typing (MLST) of hundreds of P. larvae
isolates from all over the world.5,7 These genotypes also diﬀer
phenotypically with respect to spore and colony morphology,
metabolism, and most importantly virulence.5,8,9 Therefore, the
classication of the species into ERIC genotypes is of biological
relevance. The genotypes ERIC I and ERIC II are regularly iso-
lated from infected colonies worldwide, whereas ERIC III and
ERIC IV are only represented by few historical isolates in type
culture collections.10 Hence, only P. larvae ERIC I and ERIC II
are of practical importance and will be covered in this review.
Comparative exposure bioassays have demonstrated that the
genotype ERIC II is more virulent on the larval level than ERIC I.
It commonly kills bee larvae within 6–7 days, while ERIC I
strains need up to 12 days to kill all infected larvae.11 These
diﬀerences on the individual larval level translate to diﬀerences
in virulence on the colony level because the earlier larvae die the
more eﬃciently they can be removed by nurse bees engaged inNat. Prod. Rep., 2015, 32, 765–778 | 765
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View Article Onlinebrood hygiene as part of the social immune response of honey
bees.12 The social immune response is better adapted to contain
ERIC II infections than ERIC I infections because most ERIC II-
infected larvae die early and, hence, these are more eﬃciently
removed from the colony than the slower dying ERIC I-infected
larvae. This leads to the paradoxical situation that P. larvae
ERIC II is less virulent on the colony level than ERIC I.8
From the bacterium P. larvae only the spores are infectious
and only young larvae (up to the age of 36 hours aer egg
hatching) are susceptible to infection.4,13 Hence adult honeySebastian Mu¨ller was born in
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766 | Nat. Prod. Rep., 2015, 32, 765–778bees do not become infected by the uptake of P. larvae endo-
spores.14,15 Although only bee larvae are killed by P. larvae, the
resulting lack of oﬀspring ultimately leads to the collapse of the
entire colony. In consequence weakened and collapsing colo-
nies are likely robbed by strong colonies. Because the honey of
P. larvae infected colonies is contaminated by P. larvae spores,
bees robbing the food stores of such colonies eﬃciently trans-
mit the disease to their own colonies.
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Fig. 1 Pathogenesis of P. larvae infections in honey bee larvae. The
non-invasive phase of infections comprises the ingestion of P. larvae
spores by na¨ıve larvae through spore contaminated larval diet (I–II).
The spores germinate in the larval midgut (III) where the vegetative
bacteria proliferate massively until they occupy nearly the entire
midgut lumen (IV). The invasive phase of infection is initiated by the
total destruction of themidgut peritrophicmatrix enabling the bacteria
to attack and cross the epithelial barrier (V). By then the infected larva is
dead and P. larvae totally degrades the cadaver to a ropy mass before
bacterial sporulation occurs. The ropy mass consisting of billions of
spores dries down to the so called ‘foulbrood scale’. Nurse bees trying
to clean the brood cell become contaminated by these spores and
transmit them to na¨ıve larvae when feeding them. P. larvae secondary
metabolites exhibiting antimicrobial activity might play a role during P.
larvae proliferation in the midgut lumen (IV) by eliminating bacterial
and fungal competitors and during the degradation of the larval
remains to a ropy mass (VI) by preventing saprophytes to assist in
degradation.
Fig. 2 Role of several recently identiﬁed virulence factors during
pathogenesis of P. larvae infections. (A) P. larvae proliferating in the
larval midgut will encounter microbial competitors soon the larval
food is supplemented by honey and pollen both containing bacterial
spores, bacteria, and fungi. Secondary metabolites like paenilamicin or
the paenilarvins will enable P. larvae (i) to defend the niche “larval gut”
and (ii) to outcompete saprophytes during degradation of the larval
cadaver thus ensuring that a pure culture of P. larvae prevails in the
end. (B) The larval midgut epithelium is protected against pathogen
attack by a chitin-containing peritrophic matrix (pink structure in A and
B). P. larvae expresses PlCBP49, a novel, chitin-degrading enzyme.
Total degradation of the peritrophic matrix by PlCBP49 is the key step
during pathogenesis of P. larvae infections and marks the transition
from the non-invasive to the invasive life style of P. larvae. (C) two
toxins, Plx1 and Plx2, are exclusively expressed by P. larvae ERIC I. For
both, a role as virulence factor during pathogenesis has been experi-
mentally demonstrated. These toxins most likely act on the epithelial
cells, once the protective peritrophic matrix has been degraded. P.
larvae then breaches the epithelial layer via the paracellular route and
invades the hemocoel. By then the infected larva is dead and P. larvae
starts to decompose the larval cadaver to a ropy mass. (D) The S-layer
protein SplA is exclusively expressed by P. larvae ERIC II. SplA mediates
adhesion of P. larvae to the midgut epithelial cells, an important step
during pathogenesis of P. larvae ERIC II infections. Most likely,
degradation of the peritrophic matrix is a prerequisite for bacterial cell
adhesion. Factors used by P. larvae ERIC II to accomplish breaching of
the epithelium and invading the hemocoel are still elusive. Once the
infected larva is dead, P. larvae starts to decompose the larval cadaver
to a ropy mass.
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View Article Onlinein the larval midgut (Fig. 1). The vegetative bacteria then
massively proliferate in the midgut lumen. During this non-
invasive phase of infection, no damage to the epithelial cell
layer can be observed16 although the protective peritrophic
matrix (PM) might already be aﬀected (Fig. 2A and B).17 P. larvae
is able to metabolize sugars18 and crystalline chitin,17 hence, the
larval food and chitin containing larval structures like the PM
can serve as nutrition during this phase of infection (Fig. 2B).17
The invasive phase of the infection starts when the PM is
degraded17,19 and the epithelial layer is attacked and penetrated
by P. larvae (Fig. 2C and D).16 The bacteria invade the larval
haemocoel (Fig. 1); a step that coincides with larval death.16
These characteristics of infection are shared by all P. larvae
genotypes and the degradation of the larval PM has been shown
to be a key step in AFB pathogenesis.17,19 The chitin-degrading
protein PlCBP49 is responsible for PM degradation and is a
unifying feature of pathogenesis reported to be expressed by
both genotypes, ERIC I and ERIC II (Fig. 2B).19 In addition,
genotype-specic virulence factors have been identied and it
was proposed that P. larvae ERIC I and ERIC II follow diﬀerent
strategies when nally attacking and killing the infected larva
(Fig. 2C and D).9,20 The ERIC I-genome harbors several func-
tional toxin genes which are disrupted and, hence, presumably
non-functional in the ERIC II-genome.9 Two of the ERIC I-
specic toxins (Plx1, Plx2) have been characterized in more
detail (Fig. 2C).21 Plx1 and Plx2 are novel AB-toxins [for reviews
on this class of toxins see Falnes and Sandvig22 and SimonThis journal is © The Royal Society of Chemistry 2015 Nat. Prod. Rep., 2015, 32, 765–778 | 767
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View Article Onlineet al.23] and their expression could be linked to virulence.21 Plx1
is a single-chain AB-toxin belonging to an enigmatic AB-toxin
family21 which also comprises MTX1 expressed by the entomo-
pathogen Lysinibacillus sphaericus and the pierisin-like toxins
expressed by some butteries of the family Pieridae (Lepidop-
tera).24 Plx2 is a binary AB-toxin and its A-moiety resembles C3-
like exoenzymes.21 The cellular targets of these novel AB-toxins
still await identication.21 The ERIC II-genome harbors a
functional S-layer protein gene (splA) which is mutated and,
hence, non-functional in the ERIC I-genome.25 Accordingly,
expression of S-layer proteins could only be demonstrated in P.
larvae ERIC II.26 The P. larvae protein SplA was shown to
mediate adhesion of P. larvae to primary bee midgut cells and
expression of SplA could be linked to virulence of P. larvae ERIC
II (Fig. 2D).25 The steps following P. larvae ERIC II adhesion to
the midgut epithelium and those enabling the bacteria to
penetrate the epithelial cell layer still remain elusive
(Fig. 2D).25,26 These functionally characterized, genotype-
specic virulence factors and genomic diﬀerences between P.
larvae ERIC I and ERIC II clearly point to diﬀerent virulence
strategies pursued by ERIC I and ERIC II.9,20 However, irre-
spectively of the strategy, all P. larvae infections result in larval
death and in the larval cadaver being converted in the brood cell
to a ropy mass while non-infected, healthy larvae undergo
metamorphosis and nally emerge as adult bees from the brood
cell. Interestingly, this ropy mass is usually a pure culture of P.
larvae,27,28 suggesting that P. larvae has some mechanism to
outcompete other bacteria and especially saprophytes that have
been reported to be present in the larval gut.29 Therefore the
recent identication of secondary metabolite gene clusters in
the genome of P. larvaemay contribute to facilitate interactions
with potential competitors (Fig. 2A).
The species Paenibacillus larvae has originally been classied
as Bacillus larvae.28 However, in 1991 the genus Bacillus was
analyzed by comparative small-subunit rRNA (16S rRNA)
sequence analysis and it was demonstrated that this genus
comprised ve phyletic lines, rRNA group 1–5 bacilli.30 AFig. 3 Graphical circular maps of the chromosome of Paenibacillus larva
on the forward and reverse strand are shown in blue. The inner circles sh
indicating higher and lower values than average, respectively. NRPS and
Black: monomodular NRPS, blue: sevadicin gene cluster, red: paenilamici
gene cluster. In ERIC I (A) the correspondent gene clusters are shown in
768 | Nat. Prod. Rep., 2015, 32, 765–778subsequent extensive taxonomic revision revealed that the rRNA
group 3 bacilli including Bacillus larvae were considerably
distinct from the other Bacilli and, hence, they were reclassied
as the new genus Paenibacillus.31 The genus Paenibacillus
comprises several bacterial species formerly known as Bacilli
like P. alvei and P. polymyxa. As the prex Paeni reects, Pae-
nibacilli are ‘almost’ Bacilli and they share several features and
properties with Bacilli. Bacilli are known to synthesize various
secondary metabolites, such as lanthipeptides, lipopeptides,
polyketides and other small molecules.32 Representatives of
such compounds known for decades are the cyclic peptide
antibiotics gramicidin S and tyrocidine, the lipopeptides sur-
factin and mycosubtilin and the siderophore bacillibactin.33–36
Like the genus Bacillus, Paenibacillus also seems to be an
interesting source of bioactive natural products, although to
date only few examples exist: P. polymyxa is known to produce
polymyxin and fursaricidin37,38 and Paenibacillus elgii B69
produces the catechol-type siderophore paenibactin, which is
closely related to the Bacillus siderophore bacillibactin.39
Furthermore, Paenibacillus sp. F6-B70 was described to produce
the macrolide antibiotic paenimacrolidin, which is active
against methicillin-resistant Staphylococcus aureus.40 A cyclic
lipopeptide, called battacin (octapeptin B5), was isolated from a
Paenibacillus tianmuensis soil isolate and showed antibacterial
activity against multidrug-resistant Gram-negative bacteria.41Secondary metabolites from P. larvae
It was not until the entire genome sequences of P. larvae ERIC I
and ERIC II were available9 that the complex giant gene clusters
coding for secondary metabolites in the genomes of P. larvae
ERIC I and ERIC II could be identied and correctly assembled
(Fig. 3).9 Sequencing and annotation of the genomes of P. larvae
strain DSM25430 (genotype ERIC II; 4 056 006 bp) and P. larvae
strain DSM25719 (genotype ERIC I; 4 579 589 bp) facilitated the
bioinformatics analysis of the genes, particularly of those being
involved in pathogenesis and secondary metabolite productione. (A) ERIC I DSM25719 and (B) ERIC II DSM25430. Open reading frames
ow ﬁrst GC% content and GC skew [(G – C)/(G + C)] purple and olive
PKS gene clusters are highlighted from the CDS grey bar. In ERIC II (B)
n gene cluster, yellow: paenilarvin gene cluster and purple: bacillibactin
the same colors. Circular maps were drawn using dnaplotter.81
This journal is © The Royal Society of Chemistry 2015
Fig. 4 NRPS and NRPS/PKS hybrid gene clusters harbored by P. larvae ERIC I and II. (A) The dhb gene cluster is harbored by both genotypes and
responsible for the biosynthesis of the siderophore bacillibactin. (B) A monomodular NRPS-like gene cluster responsible for the biosynthesis of
unknown compound(s). (C) The lipopeptide gene cluster of ERIC II is responsible for the biosynthesis of the paenilarvins. The genotype ERIC I
harbors a signiﬁcantly shorter form of the gene cluster; the corresponding secondary metabolite is not known yet. (D) The sev gene cluster of the
genotype ERIC II is responsible for the biosynthesis of the tripeptide sevadicin. The homologue gene cluster of the genotype ERIC I is slightly
bigger; the corresponding secondary metabolite is not identiﬁed yet. (E) The pam gene cluster is harbored by both genotypes and is responsible
for the biosynthesis of the complex NRPS/PKS hybrid antibiotics paenilamicins. Genes responsible for precursor biosynthesis (blue), genes
responsible for resistance/transport (orange), genes responsible for transcriptional regulation (red), genes of unknown function/hypothetical
proteins (white). C: condensation domain; A: adenylation domain; T: thiolation domain; TE: thioesterase domain; TR: thioesterase reductase
domain; AMT: class-III aminotransferase domain; E: epimerization domain; MT: methylation domain; KS: ketosynthase domain; AT: acyl
transferase domain; KR: ketoreductase domain; ACP: acyl carrier protein.
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View Article Online(Fig. 3 and 4).9 One NRPS was suggested to have similarities to
the biosynthetic machinery of the siderophore bacillibactin and
one NRPS/PKS hybrid gene cluster was suggested to encode the
biosynthesis of a lipopeptide from the iturin family. An entirely
cryptic cluster was a trimodular NRPS gene cluster which
showed no apparent similarity to known gene clusters of other
bacteria. A complex NRPS/PKS hybrid gene cluster showed
similarities to the zwittermicin and xenocoumacin gene clusters
as well as to other gene clusters dedicated to be responsible for
the biosynthesis of NRP prodrugs. We set out for a genetic and
biochemical characterization of these gene clusters followed by
analytical characterization of their biosynthetic products as
basis for elucidating their biological role in AFB pathogenesis.This journal is © The Royal Society of Chemistry 2015Bacillibactin – occurrence of
siderophores in P. larvae
The gene cluster of P. larvae coding for the siderophore
biosynthesis shows strong homology to the bacillibactin
biosynthesis gene clusters of the Bacillus cereus sensu lato group
and of Bacillus subtilis as well as to the paenibactin biosynthesis
gene cluster of Paenibacillus elgii 69.42 Likewise to the bacilli-
bactin gene cluster the P. larvae gene cluster was named dhb
cluster (Fig. 4A).42 The dhb cluster is about 11 kbp in size and
consists of ve genes (dhbA, dhbC, dhbE, dhbB, and dhbF),
which were annotated to encode for a 2,3-dihydro-2,3-dihy-
droxybenzoate dehydrogenase (DhbA), an isochorismateNat. Prod. Rep., 2015, 32, 765–778 | 769
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View Article Onlinesynthase (DhbC), a DHB-AMP-ligase (DhbE), an iso-
chorismatase (DhbB), and a dimodular peptide synthetase
(DhbF), respectively. On the protein level DhbACEBF of P. larvae
and DhbACEBF of B. cereus show a high similarity between 70–
79%. Proteins DhbA, B and C are predicted to synthesize 2,3-
dihydroxybenzoate (DHB) from chorismate. The 60 kDa DHB-
AMP-ligase DhbE with a similarity of 73% to DhbE of B. cereus is
a stand-alone A domain, predicted to activate DHB. DhbF, with
a similarity of 71% to DhbF of B. cereus, is a 267 kDa dimodular
NRPS. The specicity-conferring amino acid sequence (DILQV-
GLIWK) of the A-domain is identical to DhbF1 of B. subtilis
which activates Gly.35 The second A domain (DFWNIGMVHK) is
identical to DhbF2 of B. subtilis and activates Thr.35 Both NRPSs
DhbF1 and DhbF2 show a typical arrangement with a conden-
sation (C) domain, an adenylation (A) domain and a thiolation
(T) domain. The biosynthesis works in an iterative manner ofFig. 5 Nonribosomally synthesized metabolites by P. larvae.
770 | Nat. Prod. Rep., 2015, 32, 765–778three cycles and in the nal stage, the C-terminal thioesterase
(TE) domain of DhbF2 performs cleavage of the nal peptide
from the NRPS machinery under cyclisation to the macro-
lacton.35 Initially bioinformatic studies suggested the dhb
cluster of P. larvae to encode for the NRPS machinery to
synthesize paenibactin, a close bacillibactin homolog with Ala
instead of Gly.39 For P. larvae strain DSM25430 (ERIC II) and
strain DSM25719 (ERIC I) a combination of gene inactivation
and mass spectrometric fragmentation analyses performed by
our groups revealed that the NRPS machinery synthesizes the
catechol-type siderophore bacillibactin and not paenibactin as
expected before.42 Bacillibactin is the cyclic trimeric lactone of
2,3-dihydroxybenzoyl-Gly-L-Thr,35 which was assigned based on
bioinformatics analysis and comparison with a reference
compound from B. subtilis (Fig. 4). In general the dedicated
function of siderophores is to secure iron supply under low ironThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineconditions.43,44 For most pathogenic bacteria iron is a limiting
factor and both, pathogen and host are competing for iron.
Therefore, many pathogens, but also non-pathogenic bacteria
synthesize and secrete siderophores as Fe3+ scavengers in iron
limiting conditions. Comparison of wild-type strains and the
appropriate gene inactivation strains (DdhbF) of both genotypes
in larval infection assays however revealed no signicant
diﬀerences neither in total larval mortality nor in disease
progression (cumulative larval mortality).42 Therefore, bacilli-
bactin cannot be regarded as a virulence factor of P. larvae. In
literature both is described, siderophores that act as virulence
factors and siderophores not involved in pathogenicity.
Recently, it could be shown that a B. cereus strain, unable to
produce bacillibactin, showed an attenuated bacterial patho-
genesis in insects.45 However, for a B. anthracis strain, insuﬃ-
cient in bacillibactin production, no phenotypical diﬀerences
could be detected compared to the wild-type strain, suggesting
that bacillibactin has no role in virulence.46Paenilarvins – iturin-like lipopeptide
biosynthesis
As mentioned above, genotype ERIC II encodes a 37 kbp
hybrid PKS/NRPS gene cluster responsible for the biosynthesis
of iturin-like lipopeptides, the paenilarvins (Fig. 4B and 5).47
The iturins are structurally characterized by a macrocyclic
heptapeptide core with an N-terminal b-amino fatty acid of
various chain lengths.48 The b-amino group forms the macro-
lactam with the C-terminus of the heptapeptide. ERIC II
contains one gene cluster with four ORFs of the same tran-
scriptional directionality (Fig. 4B). The gene cluster arrange-
ment is strongly reminiscent of the gene clusters responsible for
the biosynthesis of the Bacillus lipopeptides iturin A and
mycosubtilin.34,49 The rst gene (c18780) encodes a trans-acting
acyltransferase, which shows 63% sequence identity with ItuD
from the iturin A biosynthesis. The initial PKS/NRPS encoded by
c18770 shows 71% identity to the PKS/NRPS MycA of the
mycosubtilin biosynthesis. Gene c18770 encodes the biosyn-
thesis machinery for acylation and PKS-mediated extension of
the acyl chain under involvement of the trans-acting acyl-
transferase and the reductive amination of the lipid chain by
the class-III aminotransferase domain. Furthermore, the NRPS
module for condensation of the rst amino acid is encoded by
c18770. Four additional A domains are found in c18760,
whereas NRPS4 and 5 harbor epimerization domains for the
stereochemical conversion of the activated L-amino acid to the
cognate D-amino acid. On the protein level c18760 shows 72%
identity with the NRPS MycB from Bacillus atrophaeus. Gene
c18750 encodes for the NRPS responsible for the incorporation
of the last two amino acids of the lipopeptide, whereas NRPS8
harbors an epimerization (E) domain. Additionally, the nal
NRPS contains a thioesterase domain, responsible for cyclisa-
tion and release of the lipopeptide.
The isolation and structure elucidation was achieved for
three new iturin-family lipopeptides named paenilarvins
accomplished from the P. larvae strain DSM25430.47 FourThis journal is © The Royal Society of Chemistry 2015additional derivatives of the paenilarvins were identied
present in low amounts, but were not further characterized.
Mass spectrometric data led to suggest variations in chain
length and stereochemistry in the b-amino fatty acid side
chain.47 Paenilarvin A shows an identical amino acid sequence
as the recently identied mojavensin A from Bacillus mojavensis
B0621A, but diﬀers in the b-amino fatty acid side chain
(Fig. 5).50 In paenilarvin B, Asn at position 2 is exchanged by Asp
(Fig. 4). Paenilarvin C is a paenilarvin A analogue shortened by
two methylene groups in the b-amino fatty acid side chain
(Fig. 5). The biosynthesis begins with the activation of a fatty
acid, which is likely derived from the primary metabolism.
Subsequently, the fatty acid is loaded onto the rst T domain,
followed by a chain extension with malonyl-CoA catalyzed by
PKS module and the trans-acting acyltransferase (c18780). The
action of the aminotransferase (AMT) domain converts the
extended fatty acid into the b-amino fatty acid by reductive
transamination. The b-amino fatty acid is then condensed with
Asx, catalyzed by the condensation domain of the rst NRPS
module. The next four NRPSmodules, all expressed by the same
gene (c18760), catalyze the activation and condensation of Tyr,
Asn, Gln and Pro, respectively. Hereby, the rst two NRPS
harbor epimerization domains, resulting in D-Tyr and D-Asn in
the nal peptide. The last gene of the cluster (c18750) encodes
the nal two NRPS, responsible for the activation and conden-
sation of two Asn, whereas the rst Asn is converted to D-Asn by
the epimerization domain. The last domain of the c18750 gene
product is a thioesterase domain, which catalyzes the cyclisa-
tion and release of the paenilarvins.
Most members of the iturin family lipopeptides show strong
antifungal and cytolytic activity by disruption of the plasma
membrane, whereas the fatty acid chain length seems to be
important for the bioactivity.51,52 In contrast to their good
antifungal properties, most iturin-type lipopeptides show no or
only weak antibacterial activity.48 The same was observed for the
paenilarvins: neither paenilarvin A, nor paenilarvin B showed
antibacterial activity against Gram-positive or Gram-negative
bacteria, but both compounds were active against various la-
mentous fungi and yeasts: Mucor hiemalis, Aspergillus clavatus,
Botryotinia fuckeliana, Hormoconis resinae, Penicillium capsu-
latum, Saccharomyces cerevisiae, Rhodotorula glutinis, Candida
albicans, Wickerhamomyces anomalus, Nematospora coryli, Tri-
chosporon oleaginous, Debaryomyces hansenii and Pichia mem-
branifaciens. Paenilarvin A was signicantly more active (MIC ¼
2.1–4.2 mg mL1) than Paenilarvin B (MIC ¼ 8.3–33.3 mg mL1).
In addition to the antimicrobial assays, the paenilarvins were
also tested in a cell culture assay against the mouse broblast
cell line L929. Thereby, paenilarvin A and B both showed also
signicant cytotoxicity (paenilarvin A: IC50 ¼ 4 mg mL1; pae-
nilarvin B: IC50 > 10 mg mL
1). The authors were further inter-
ested in the eﬀects of paenilarvin A and B against bee larva.
Therefore, bee larvae were fed with paenilarvin A or B (5 mg) at
days 4, 5 and 6 and larval mortality was recorded for 22 days. For
both compounds a signicant activity against bee larvae could
be demonstrated: for paenilarvin A the mortality was 25%
higher and for paenilarvin B 35% higher compared to the larval
control group. In this study, paenilarvin C was not tested in anyNat. Prod. Rep., 2015, 32, 765–778 | 771
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View Article Onlineof the assays, whereas the eﬀects of the shortened lipid chain
for the increased bioactivity seem interesting. The authors
estimate their studies on bee larvae as preliminary data, which
have to be conrmed with diﬀerent concentrations of
compounds and with larvae at diﬀerent developmental stages.
The question whether paenilarvins are required by P. larvae to
ght fungi as ecological niche competitors or to kill bee larva
could not be answered in this study. The authors discussed a
further hypothesis for the role of the paenilarvins: at subin-
hibitory concentrations they could act as signaling molecules,
which is a hypothesis already suggested previously for other
systems.53,54 In contrast, the corresponding gene cluster from P.
larvaeDSM25719 (genotype ERIC I) is much smaller (12.5 kbp)
and contains only two genes (Fig. 4B). In this context only the
biosynthetic machinery for the acylation, PKS-mediated exten-
sion and amidation as well as the NRPS for the incorporation of
the rst amino acid are present (Fig. 4B). The NRPS shows
homology to NRPS9 of ERIC II, encoded by gene c18750.
Accordingly, the ERIC I gene cluster could be responsible for the
biosynthesis of another not yet identied (lipo)peptide or might
be even inactive. However, no studies on the ERIC I gene cluster
were published yet.Sevadicin – A nonribosomal tripeptide
The genome of strain DSM25430 (genotype ERIC II) contains an
11.7 kbp gene cluster (sev cluster) consisting of only two genes
(sevA and sevB) and coding for three NRPS modules without the
presence of genes coding for tailoring enzymes or transport
(Fig. 4C). In the NRPS genes epimerization (E) domains that
catalyze the inversion of the a-stereocenter of amino acids are
located in the rst two modules while a TE domain was located
at the C-terminal part of module 3. The predictions for A
domain specicities were ambiguous, such that sequence
details as well as peptide size were elusive. Help came from gene
inactivation strains, incapable of sevadicin production. Subse-
quent analytical characterization rendered a linear peptide,
called sevadicin with the sequence D-Phe–D-Ala–Trp (Fig. 5).55
While for strain DSM25430 (ERIC II) a peptide could be iden-
tied, strain DSM25719 (ERIC I) contains an NRPS gene cluster
of ve genes with four NRPS modules (Fig. 2C). The product of
gene c02110 is annotated as a lone-standing A domain, pre-
dicted to activate Cys. At the protein level SevA and the product
of c02090 are highly homologous, whereas the ERIC I NRPS is
slightly shorter (927 aa) compared to SevA (1080 aa). Compar-
ison of the ten highly conserved core motifs56 of the adenylation
domains revealed that the ERIC I A domain lack the core motifs
A1 and A2, suggesting an inactive module. Hereby, the
involvement of the lone-standing A domain (gene c02110) as a
trans-acting A domain could be hypothesized. Due to our
inspection, the NRPS module encoded by gene c02100 seems to
be active and is predicted to activate Val. The NRPS module
encoded by c02120 shows a high homology to NRPS2 of SevB,
with the exception of the rst C domain. However, the C-
terminal C domain is homologous to the C domain of NRPS3 of
SevB. NRPS4 (encoded by c02130) is identical to the A–T–TE772 | Nat. Prod. Rep., 2015, 32, 765–778domains of SevB. Nevertheless, until to date no peptide was
identied in ERIC I secretome.
Testing the secretome of the sev gene inactivation strain
showed that the antibacterial activity was clearly decreased
while not completely lost compared to the wild-type secretome.
Synthetic sevadicin showed only weak antibacterial activity
against B. megaterium, suggesting alternative functions of sev-
adicin. These may be signaling networks, as it has recently
shown for the aureusimines: nonribosomally synthesized
diketopiperazine-like compounds produced by Staphylococcus
aureus,57 which might be involved in regulating the expression
of genes associated with virulence and with regulatory and
redox-associated genes,58 suggesting a potential function for
regulating a metabolic switch of S. aureus. Interestingly, P.
larvae previously has also been hypothesized to undergo a
metabolic switch during pathogenesis.16 In the larval gut during
the non-invasive phase, P. larvaemainly takes its nutrients from
the larval food ingested by larvae.18 Subsequently during the
invasive phase, P. larvae switches to consuming larval struc-
tures, rst the peritrophic membrane protecting the gut,17,19
then totally decomposing all larval tissues yielding a ropy mass
consisting of a pure P. larvae culture.Paenilamicins – complex peptide–
polyketide hybrids
A remarkably complex NRPS/PKS hybrid gene cluster (pam gene
cluster) of about 60 kbp, which shows no greater similarities to
any known gene clusters, is found in both genotypes ERIC I and
ERIC II, respectively (Fig. 4D). The biggest part of the gene
cluster consists of ve NRPS (pamC-E, pamH and pamN), two
PKS (pamF and G) and two PKS/NRPS hybrid genes (pamA and
B).59 Six genes are involved in precursor biosynthesis (pamK and
pamO-S). Two genes have a likely function in transport and/or
resistance (pamZ and pamJ). PamM is most probably respon-
sible for transcriptional regulation, whereas PamL is a lone-
standing acyl-carrier protein (ACP) and PamI shows weak
homology to BtrH-like proteins.
The considerably challenging structure elucidation was
achieved by isolating four derivatives, named paenilamicins
(Fig. 4).60 Based on the structures of paenilamicin A1/A2 and
paenilamicin B1/B2 a comprehensive biosynthetic picture could
be drawn (Fig. 6A): the A domain of PamA shows relaxed
substrate specicity andmust be capable of activating either Lys
or Arg. The biosynthesis continues with a PKS1-mediated
Claisen condensation with malonyl-CoA and a ketoreductase-
catalyzed reduction of the amino acid carbonyl to yield a
secondary alcohol and the generation of a cadaverine (Cad) or
agmatine (Agm) residue, respectively. A subsequent Claisen
condensation with an unusual (2R)-hydroxymalonyl is then
performed by the PKS part of the PKS/NRPS hybrid PamB, fol-
lowed by another ketoreduction. (2R)-Hydroxymalonyl-ACP is
most likely provided by the catalytic action of PamKOPQ,
proteins that show high similarity to (2R)-hydroxymalonyl-ACP
biosynthesis proteins known from the zwittermicin biosyn-
thesis.61,62 PamK shows 78% similarities to the 3-hydroxyacyl-This journal is © The Royal Society of Chemistry 2015
Fig. 6 The pam gene cluster from P. larvae DSM25430 and proposed biosynthesis of paenilamicins and precursors. (A) The proposed assembly
line of prepaenilamicin B1 and its activation to paenilamicin B1. The prepaenilamicin B1 assembly line starts presumably with the activation of
acyl-D-Asn (grey; R¼ fatty acid) by NRPS0 (pamN). Prepaenilamicin B1 is released in a TE-independent fashion by the nucleophilic condensation
of 4,3-spermidine to Gly. Prepaenilamicin is potentially activated by the transmembrane transporter/peptidase PamJ (grey boxed). Genes
responsible for precursor biosynthesis (dark-blue), genes responsible for resistance/transport (orange), genes responsible for transcriptional
regulation (red), genes of unknown function/hypothetical proteins (white). (B) Putative (2R)-hydroxymalonyl-ACP biosynthesis with the glycolysis
intermediate 1,3-bisphospho-D-glycerate as substrate. (C) L-Dap biosynthesis from O-phospho-L-Ser and L-Glu. C: condensation domain; A:
adenylation domain; T: thiolation domain; E: epimerization domain; MT: methylation domain; KS: ketosynthase domain; AT: acyl transferase
domain; KR: ketoreductase domain; ACP: acyl carrier protein; PLP: pyridoxal 50-phosphate.
This journal is © The Royal Society of Chemistry 2015 Nat. Prod. Rep., 2015, 32, 765–778 | 773
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View Article OnlineCoA-dehydrogenease (ZmaG), PamO shares 88% similarities
with the FkbH-like protein (ZmaN) and PamP is annotated as an
ACP with high similarity (86%) to ZmaD/H, whereas PamQ is an
acyl-CoA dehydrogenase with 89% similarity to ZmaE. The
proposed biosynthesis of (2R)-hydroxymalonyl-ACP requires
glycolysis intermediate 1,3-bisphospho-D-glycerate as a
substrate (Fig. 6B).61 The 1,3-bisphospho-D-glycerate is tethered
to PamP and dephosphorylated by PamO. The glycerate-ACP is
subsequently oxidized by PamK and PamQ, respectively yielding
in (2R)-hydroxymalonyl-ACP (Fig. 6B). Next, a D-Ala is condensed
to the building block by NRPS2. Hereby, D-Ala is not stereo-
chemically converted by an epimerization domain of NRPS2 (no
E domain could be detected by sequence analysis). Because of
the occurrence of a gene coding for an alanine racemase it is
proposed that D-Ala is provided by this enzyme and directly
activated by the A domain, as it was shown for cyclosporin and
HC toxin.63,64 The biosynthesis continues with the condensation
of the amino acids N-methyl-diaminopropionic acid (mDap), D-
Lys/D-Orn, and Ser. Thereby, Dap is provided by PamS and
PamR from the substrates O-phospho-L-Ser and Glu (Fig. 6C).65
PamS is a 2,3-diaminopropionate biosynthesis protein (SbnB-
like, 80% similarity) and PamR is a pyridoxal-5'-phosphate-
dependent protein subunit b (SbnA-like, 80% similarity), which
are known from the Dap biosynthesis of the staphyloferrin B
biosynthesis (Fig. 6C).65 The presence of N-methyl-Dap is sup-
ported by an N-methylation domain in the NRPS PamC. In
contrast to common N-methylations occurring at the peptide
bond, this N-methylation is located in the amino acid side-
chain. As already described for the A domain of PamA, the A
domain of PamD shows also a relaxed substrate specicity and
is capable to activate Lys and Orn, resulting in another two
paenilamicin derivatives. The biosynthesis proceeds with two
consecutive condensations of malonyl-CoA with followed
ketoreductions catalyzed by PKS3 (PamF) and 4 (PamG).
Together, PamE-G proteins are responsible for the biosynthesis
of the structural motif galantinic acid (Gla). Interestingly, the
same structural motif is found in the siderophor anachelin
produced by the cyanobacterium Anabaena cylindrical, sug-
gesting the same biosynthetic setup.66 Catalyzed by the
bimodular NRPS PamH, another mDap and a Gly are attached.
An interesting hypothesis is provided for the attachment of the
C-terminal 4,3-spermidine. The protein PamI shows homology
to the BtrH protein family. A functional classication for a BtrH
protein was given for the biosynthesis of butirosin, where the
BtrH protein is described as an aminoglycoside 1-N-acyl-
transferase responsible for the ligation of the aminoglycoside
side chain of butirosin.67 At the C-terminus of PamH (aer the T
domain of the Gly specic NRPS) a similar domain could be
identied and the authors hypothesized that the domains could
somehow be responsible for the directional attachment of 4,3-
spermidine to the paenilamicins and thereby release of the
peptide from the NRPS.
Another interesting aspect is the suggested production of a
prodrug called prepaenilamicin, which parallels the (pre)xen-
ocoumacins, compounds from Xenorhabdus nematophila
described by Bode and coworkers.68,69 Therein two genes seem
to be conserved: a NRPS specic for the activation of (acyl)-D-Asn774 | Nat. Prod. Rep., 2015, 32, 765–778or (acyl)-D-Gln and a D-Asn specic carboxypeptidase. For the
pam system the A domain of NRPS8 (PamN) is predicted to
activate Asn or Asx by three diﬀerent prediction tools and
harbors an E domain responsible for transformation of L-Asx
into D-Asx. Moreover, PamN is homologous to the starting
module XcnA of the xenocoumacin biosynthesis gene cluster as
well as to starting modules of other biosynthesis gene clusters
responsible for the biosynthesis of nonribosomal prodrugs like
amicoumacin (B. pumilus), zwittermicin (B. thuringiensis), col-
ibactin (E. coli), and other similar NRPS/PKS clusters with
unknown products that all are predicted to activate Asn or
Asx.68,69
Bode and coworkers proposed two diﬀerent architectures of
the peptidases: type I with XcnG as the model peptidase
comprises a signal peptide followed by a periplasmatic D-Asn
specic carboxypeptidase and three C-terminal transmembrane
helices. Type II has a signal peptide followed by a peptidase
domain, nine transmembrane helices and an ABC transporter.68
The peptidase subunit is responsible for the specic cleavage of
the acylated D-Asp moiety of the prexenocoumacins, resulting in
the bioactive xenocoumacins.68 The protein PamJ was found to
be homologous to XcnG suggesting that PamJ could be a
peptidase (Fig. 6A). Although PamJ shows structural diﬀerences
(type II architecture) to XcnG (type I architecture) a comparable
biosynthesis and pro-drug activation mechanism seems to be
likely (Fig. 6A). The described pro-drug mechanism is a strategy
of the producer strain to avoid self-damaging.
For the paenilamicins antibacterial activity against various
Gram-positive strains (P. alvei, B. subtilis, B. licheniformis, and B.
megaterium) was found, which are all strains with a potential
association with honey bees.59 Beside the antibacterial activity
the paenilamicins exhibit also antifungal activity against yeasts
(P. pastoris and S. cerevisiae) and the plant pathogenic la-
mentous fungus F. oxysporum.59 Cytotoxic eﬀects found in vitro
against the Trichoplusia ni (Lepidotera-derived) insect cell line
Tn5, suggested that paenilamicin could act as a toxin against
bee larvae. However bee larva infection assays with a P. larvae
strain unable to synthesize paenilamicin (P. larvae DpamA)
showed no signicant diﬀerences in total mortality of bee
larvae.59 These results show that in the P. larvae/honey bee
larvae system it is obviously not always possible to infer from in
vitro data on in vivo function. Nevertheless, the authors also
analyzed the time course of infection revealing that the curve for
cumulative mortality was shied for the larval groups infected
with the mutant strain (DpamA), indicating a signicantly
delayed onset of mortality in comparison to the groups infected
with wild-type P. larvae. Accordingly, the LT100 (lethal time) also
signicantly diﬀered: wild-type P. larvae required about 8 days,
whereas the mutant strain needed 12 days to accomplish killing
of all infected larvae.59 The proposed main function of paeni-
lamicin was shown in a recently published study:60 in the cor-
responding assay larvae were co-infected with both P. larvae and
the saprophytic bacterium P. alvei. Aer larval death dead larvae
were examined for P. alvei survival by determination of P. alvei
growth on agar medium. This assay showed that only 11% vital
P. alvei could be recovered from larvae infected with wild-type P.
larvae. Interestingly, in co-infection assays where larvae wereThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineinfected with P. alvei and P. larvae DpamA the recovery rate of P.
alvei was signicantly higher (about 62%). The results of the
larvae co-infection assays show, that a main function of the
paenilamicins is outcompeting competitors in the ecological
niche larval gut and may explain why the ropy mass that
remains aer larval death is a pure culture of P. larvae (Fig. 2A).A cryptic monomodular NRPS-like
gene cluster
The genotypes, ERIC I (gene c22070) and ERIC II (gene c04880)
both contain a monomodular NRPS-like gene (Fig. 4E). It
encodes for an A domain, a T domain and a C-terminal thio-
esterase reduction (TR) domain, but lacks a C domain. The A
domain of the P. larvae NRPS-like protein is predicted to acti-
vate Phe and the module arrangement has similarities to the
fungal NRPS LnaA (1042 aa) and LnbA (1007 aa) from Aspergillus
avus NRRL3357,70 although the putative NRPS-like protein
from P. larvae (1239 aa) shares only weak homology to LnaA and
LnbA, respectively. The A domains of LnaA and LnbA speci-
cally activate Tyr and biosynthesis products are piperazine and
pyrazine derivatives, as well as a hemiacetal-containing mor-
pholine.70 In a biosynthesis model the authors suggest that Tyr
is activated by the A domains of LnaA and/or LnbA, transferred
to the T domains and subsequently reduced to yield a tyrosinal
by the catalytic action of the TR domain. Further reduction and
cyclisation is supposed to be catalyzed be the reductases LnaB
and LnbB.70 In the context of the P. larvae cluster no additional
reductases were identied, furthermore despite the NRPS gene
no further genes show homologies to the lna or lnb cluster. The
structures are reminiscent of aureusimines from S. aureus and
diketopiperazines from Streptomyces although diﬀerent
biosynthesis mechanisms as bimodular NRPS and tRNA-
dependent assembly are employed.57,71 Likewise to above
mentioned bacteria, the diketopiperazines and the piperazine/
pyrazine might play a role in a signaling networks.57,70,71 From
the present data we hypothesize that P. larvae is able to produce
related compounds which could have a similar function as
quorum sensing molecules, which needs to be proven in further
work.Gene clusters of ribosomally
synthesized secondary metabolites
Apart from the above mentioned gene clusters encoding for
nonribosomal peptides, the genotypes ERIC I and ERIC II
contain also genes encoding for the synthesis of ribosomal
peptides. The genomes of P. larvae strains DSM25430 and
DSM25719 were analyzed with the antiSMASH72 online tool to
assess the potential for the biosynthesis of bacteriocins and
ribosomally synthesized and posttranslationally modied
peptides (RiPPs).
The manual assignment of genes rendered three putative
bacteriocin and RiPP gene clusters for genotype ERIC II, thereof
one lanthipeptide and two bacteriocins. For genotype ERIC I
putative biosynthesis genes or gene cluster-like arrangementsThis journal is © The Royal Society of Chemistry 2015for eight bacteriocins and one lanthipeptide were found. In
ERIC II the lanthipeptide cluster comprises a gene (c31290)
coding for a putative lantibiotic dehydratase with a C-terminal
thiopeptide-type bacteriocin biosynthesis domain. Gene c31300
encodes a LanC-like cyclase and c31310 for a truncated ABC
transporter (183 aa). A protease was not found in the cluster, but
is also not universally found in class I gene clusters,73,74 while
however the assigned prepropeptide gene (c31270) has only
weak sequence homology to known prepropeptides. A putative
gene cluster for the biosynthesis of a bacteriocin and with
homology to gene clusters of several B. amyloliquefaciens and
B. subtilis species is gene c36580. NCBI's conserved domain
search75 showed that the C-terminal part has homologies to class
IId cyclic uberolysin-like bacteriocins.76 A putative ABC trans-
porter of 233 aa (gene c36600), could be responsible for transport
and self-resistance. Even if a large part of the genes of this cluster
could not be assigned regarding their functions one could
assume a functional gene cluster for the expression of a bacte-
riocin. Another uberolysin-like putative bacteriocin (73 aa) is
encoded by gene c40350 with 49.3% identity and 69.9% similarity
to uberolysin from Streptococcus uberis.77 The truncated gene
product of c40340 (191 aa) shows only weak homology to the
cyclizing protein UblB (535 aa),77 assuming that the P. larvae
protein is non-functional. Three putative ABC transporters are
encoded by the genes c40280, c40250 and c40240.
Probably an incomplete class II lanthipeptide gene cluster is
spanning the region 1 806 134–1 812 604, which contains a
truncated lanM-like gene and a putative prepropeptide (c19180)
with weak homology to known lanthipeptides and lacking
characteristic features of precursor peptides. Likewise, bacte-
riocin gene clusters (c05230, c05830, c21080, c21140, c24550,
c28660, c31740, c34160) putatively are disrupted or incomplete.Summary and outlook
Genome sequencing of Paenibacillus larvae strains DSM25430
(genotype ERIC II) and DSM25719 (genotype ERIC I) revealed the
presence of gene clusters coding for the synthesis of secondary
metabolites. With a size of 4 056 006 bp (ERIC II) and 4 579 589
bp (ERIC I), 2.99% and 2.23% of the genomes are devoted to the
biosynthesis of small molecules, respectively (Fig. 3).
The gene clusters encode NRPS peptides and NRPS/PKS
hybrid peptides of which four structural families have been
identied (Fig. 4 and 5). Interestingly, exclusive polyketide
synthases have not been identied. Furthermore, no gene
clusters responsible for the biosynthesis of terpenes, amino-
glycosides and other small molecules have been identied (own
analysis). Putative clusters responsible for ribosomally synthe-
sized peptides could be detected in both P. larvae genotypes,
whereas antiSMASH analysis of genotype ERIC I showed more
putative clusters (one lanthipeptide and eight bacteriocin clus-
ters) compared to genotype ERIC II (one lanthipeptide, two
bacteriocin clusters). Most clusters seem to be incomplete or
exhibited only weak homologies to known gene clusters of ribo-
somally synthesized peptides.76,78 Nevertheless, some core
precursor peptides showed homologies to known bacteriocins.79Nat. Prod. Rep., 2015, 32, 765–778 | 775
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View Article OnlineExperimental data is necessary to prove which clusters are active
and to elucidate the roles of bacteriocins and RiPPs in AFB.
In recent work four of the dedicated nonribosomal secondary
metabolites were identied and their structures characterized.
The siderophore bacillibactin is generally widespread among
Bacillus species. Since gene inactivation studies of the gene
cluster rendered no eﬀect on virulence we hypothesize that the
siderophore may be an evolutionary remnant still enabling P.
larvae to sequester iron under certain circumstances. The other
three compounds apparently have antimicrobial defense tasks:
the nonribosomal tripeptide sevadicin shows antibacterial
activity while paenilarvins, iturin-like lipopeptides, have anti-
fungal activity against various lamentous fungi and yeasts. For
iturin family lipopeptides fungicidal and strong cytolytic activity
has been described while they display no or only weak antibac-
terial activities.48,51,52 Finally, paenilamicins show both, antibac-
terial as well as antifungal activity in addition to cytotoxic activity
against insect cells.59 It is very likely, that the array of these
compounds acts in a synergistic manner as this was already
described for eﬀects on pathogenic fungi by bacillomycin and
fengycin.80 Exposure bioassays provided rst evidence for the in
vivo function of the paenilamicins during AFB pathogenesis: (i)
by killing bacterial (and maybe fungal) competitors the paenila-
micins enable P. larvae to ght its ecological niche and (ii) the
paenilamicins inuence the time-course of disease in bee larvae
although the mechanism remains elusive.59 Therefore, paenila-
micins act as virulence factors for P. larvae during larval infec-
tion. The high specialization of P. larvae on honey bees and the
uniqueness of sevadicin and paenilamicin in this bacteriummay
indicate a more intricate role of these two compounds.
Still not clear is the cytotoxicity of compounds which
becomes critical in the moment when P. larvae breaks through
the midgut lumen. While chitinases and maybe also other
enzymes dissolve cellular structures, secondary metabolites
could have a function in protecting the larval cadaver against
other bacteria and fungi that act as nutrient competitors.
Another function, especially for sevadicin due to weak anti-
bacterial activity, could be a role as a signaling molecule
involved in the regulation of biological processes, as it could be
shown for the aureusimines57,58 and other antibiotics.54
The described genomic diﬀerences between P. larvae ERIC I
and ERIC II also concern the secondary metabolite gene clus-
ters. The genome of the P. larvae genotype ERIC I harbors also
the paenilamicin and the bacillibactin clusters, although pae-
nilamicin could not be identied from fractionated secretomes
yet. Additionally, ERIC I harbors two clusters that diﬀer from
homologous clusters from genotype ERIC II, and whose prod-
ucts are not identied yet. One of these clusters is homologous
to the iturin gene cluster, which consists in contrast to the gene
cluster of ERIC II, of only two genes. One of these genes is a
trans-acting acyltransferase nearly identical to c18780 from
ERIC II Ser103Ala; the other gene is a NRPS/PKS hybrid with
high homology to gene c18770 from ERIC II, but harboring a TE
domain at the C-terminus. This cluster could be responsible for
the synthesis of another not yet identied (lipo)peptide or
might be even an inactive gene cluster. Another gene cluster
responsible for the biosynthesis of an unknown peptide from776 | Nat. Prod. Rep., 2015, 32, 765–778the genotype ERIC I is a homolog of the sev gene cluster. The
ERIC I gene cluster consists of ve genes (two genes in ERIC II)
and likely includes a trans-acting A domain in the peptide
synthesis. Close inspection of the gene cluster led us to suggest
the synthesis of a tetrapeptide. Furthermore, a monomodular
NRPS-like gene is harbored by both genotypes, whose
compounds are not identied yet. NRPS-like proteins with the
architecture A–T–TR are predominantly known from fungi.
Such as the NRPS-like proteins from the fungus A. avus, which
are responsible for the biosynthesis of metabolites involved in a
signaling network resulting in a metabolic switch. Interestingly,
also P. larvae is undergoing a metabolic switch.16 Further work
is necessary to identify all compounds produced by P. larvae and
to illuminate their functions.
In conclusion entomopathogens appear as a rich and yet
underinvestigated source of novel and structurally diverse
secondary metabolites. The bee pathogen P. larvae is no
exception to this rule and an in-depth study and characteriza-
tion of the secondary metabolites produced by the honey bee
pathogen P. larvae is highly relevant not only for bee patholo-
gists but for a broader community interested in discovering and
elucidating novel antibacterial substances. Hence, improving
our knowledge of the secondary metabolites of P. larvae will
allow a better understanding of roles of secondary metabolites
in cell biology and pathogenesis, especially in AFB. In addition,
the further characterization of novel metabolites, such as pae-
nilamicin, could bring new resources in the drug development
market.
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